Clinical Trial Update: Efficacy and Safety of Infliximab Biosimilar Remsima in Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating efficacy and safety of the infliximab biosimilar Remsima in psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Remsima (infliximab)

Snippet

Sponsor: Ghurki Trust and Teaching Hospital | Conditions: Psoriasis | Phase 4 | Status: COMPLETED